Mascoma Wealth Management LLC maintained its position in Humana Inc. (NYSE:HUM) during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 430 shares of the insurance provider’s stock at the end of the second quarter. Mascoma Wealth Management LLC’s holdings in Humana were worth $103,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HUM. Atria Investments LLC raised its position in Humana by 112.5% in the first quarter. Atria Investments LLC now owns 3,594 shares of the insurance provider’s stock valued at $741,000 after buying an additional 1,903 shares in the last quarter. Capstone Asset Management Co. raised its position in Humana by 2.0% in the first quarter. Capstone Asset Management Co. now owns 16,805 shares of the insurance provider’s stock worth $3,464,000 after buying an additional 334 shares during the period. National Pension Service raised its position in Humana by 2.2% in the first quarter. National Pension Service now owns 115,193 shares of the insurance provider’s stock worth $23,830,000 after buying an additional 2,499 shares during the period. Gulf International Bank UK Ltd raised its position in Humana by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 46,205 shares of the insurance provider’s stock worth $9,524,000 after buying an additional 620 shares during the period. Finally, Contravisory Investment Management Inc. bought a new position in Humana during the first quarter worth about $4,605,000. Institutional investors and hedge funds own 99.04% of the company’s stock.
Humana Inc. (HUM) traded up 0.04% during midday trading on Friday, reaching $235.92. The company had a trading volume of 1,013,821 shares. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $243.74. The company has a market capitalization of $34.05 billion, a P/E ratio of 24.04 and a beta of 0.91. The company’s 50 day moving average is $235.90 and its 200-day moving average is $218.69.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The firm had revenue of $13.76 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the business earned $1.86 EPS. Equities analysts expect that Humana Inc. will post $11.15 earnings per share for the current fiscal year.
WARNING: “Humana Inc. (HUM) Stake Held by Mascoma Wealth Management LLC” was originally published by BNB Daily and is the property of of BNB Daily. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at https://www.baseball-news-blog.com/2017/07/23/mascoma-wealth-management-llc-has-103000-stake-in-humana-inc-hum-updated.html.
A number of research analysts recently issued reports on HUM shares. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $256.00 target price for the company in a report on Monday, May 8th. Deutsche Bank AG assumed coverage on Humana in a report on Wednesday, April 5th. They set a “hold” rating and a $216.00 price target for the company. Argus raised Humana from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a report on Friday, June 9th. Oppenheimer Holdings, Inc. assumed coverage on Humana in a report on Thursday, March 30th. They set an “outperform” rating and a $236.00 price target for the company. Finally, Cantor Fitzgerald lifted their price target on Humana from $190.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, April 26th. Ten investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $236.00.
In related news, CEO Bruce D. Broussard sold 118,231 shares of Humana stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $225.82, for a total value of $26,698,924.42. Following the completion of the sale, the chief executive officer now owns 171,170 shares of the company’s stock, valued at approximately $38,653,609.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now directly owns 8,150 shares in the company, valued at $1,890,474. The disclosure for this sale can be found here. Insiders sold a total of 143,241 shares of company stock valued at $32,446,903 in the last quarter. 0.80% of the stock is currently owned by company insiders.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.